BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 15, 1999

View Archived Issues

Interferon gamma-1b offers possibilities as treatment for idiopathic pulmonary fibrosis

Read More

Highlights during third quarter at Hemosol

Read More

Antisense compounds from Isis target human cancer-associated mdm2

Read More

Ophidian reports progress with CDAD and IBD candidates

Read More

WHO teams up with Japanese government and industry to identify antimalarial drugs

Read More

AstraZeneca's immunomodulator H-327/86 is a novel candidate for treating atherosclerosis

Read More

Ciba Vision introduces ocular formulation of lomefloxacin in U.K.

Read More

NovoRapid now on the market in the U.K.

Read More

CDP-571 is effective in Crohn's disease: phase IIb study results announced

Read More

Antifungal microbial biotransformation products disclosed by Merck

Read More

Chugai reports progress in the development of new antiarthritics

Read More

More on proteasome inhibitor PS-519, including chemical structure

Read More

Results and progress in third quarter summarized by Neurocrine Biosciences

Read More

Agents that enhance serotonergic neurotransmission designed at Pfizer

Read More

Broad-spectrum macrolide antibiotics described by Pfizer in recent patent literature

Read More

Kotobuki presents new sulfonamide MMP inhibitors

Read More

Long-acting local anesthetics bind to multiple sites on voltage-gated Na+ channels

Read More

PhotoCure advances toward registration of Metvix during Q3 1999

Read More

Vitronectin receptor antagonists for bone disorders, etc., in development at AHP

Read More

Vapreotide superior to placebo in early treatment of portal hypertensive bleeding

Read More

Palatin-Molecular Biosystems merger will create stronger new diagnostic company

Read More

rhIL-10 reduces liver injury, normalizes serum ALT in HCV patients failing interferon

Read More

Mechanism of antioxidant action of S-17834 explored in vitro

Read More

FR-167653 examined in rat model of hepatic ischemia/reperfusion injury

Read More

Favorable phase II results announced for Valentis's VEGF165 gene medicine at AHA

Read More

VPA-985 as a novel treatment option for hyponatremia in cirrhosis: clinical results

Read More

Draximage licenses Amiscan AMI diagnostic

Read More

Chiron and Norwegian Institutes of Public Health to codevelop meningitis B/C vaccine

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 12, 2025.
  • Illustration of SCAN in Parkinson’s vs healthy subcortex

    SCAN is core circuit affected in Parkinson’s disease

    BioWorld Science
    Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
  • Woman and 3D brain

    Astellas’ ASP-2246 shows promise in stroke management

    BioWorld Science
    Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
  • 3D illustration of skin layers

    TL1A is overexpressed in hidradenitis suppurativa

    BioWorld Science
    Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for Feb. 10, 2026
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing